{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T03:36:34Z","timestamp":1783568194401,"version":"3.55.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2018,12,7]],"date-time":"2018-12-07T00:00:00Z","timestamp":1544140800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1007\/s00296-018-4212-0","type":"journal-article","created":{"date-parts":[[2018,12,6]],"date-time":"2018-12-06T21:48:05Z","timestamp":1544132885000},"page":"353-357","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Granuloma annulare development in a patient with rheumatoid arthritis treated with tocilizumab: case-based review"],"prefix":"10.1007","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9383-5722","authenticated-orcid":false,"given":"Eleftherios","family":"Pelechas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3932-6652","authenticated-orcid":false,"given":"Alexandra","family":"Papoudou-Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5193-2284","authenticated-orcid":false,"given":"Paraskevi V.","family":"Voulgari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2232-0326","authenticated-orcid":false,"given":"Alexandros A.","family":"Drosos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,12,7]]},"reference":[{"key":"4212_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2018.06.003","author":"E Kaltsonoudis","year":"2018","unstructured":"Kaltsonoudis E, Pelechas E, Voulgari PV, Drosos AA. (2018) Unmet needs in the treatment of rheumatoid arthritis. An observational study and a real-life experience from a single university center. Semin Arthritis Rheum. \n                    https:\/\/doi.org\/10.1016\/j.semarthrit.2018.06.003\n                    \n                  \n                           (epub ahead of print)","journal-title":"Semin Arthritis Rheum"},{"issue":"6","key":"4212_CR2","doi-asserted-by":"publisher","first-page":"785","DOI":"10.3899\/jrheum.170477","volume":"45","author":"ID Flouri","year":"2018","unstructured":"Flouri ID, Markatseli TE, Boki KA et al (2018) Comparative analysis and predictors of 10-year tumor necrosis factor inhibitors drug survival in patients with spondyloarthritis: first-year response predicts longterm drug persistence. J Rheumatol 45(6):785\u2013794","journal-title":"J Rheumatol"},{"key":"4212_CR3","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1080\/03009740902922612","volume":"38","author":"SA Exarchou","year":"2009","unstructured":"Exarchou SA, Voulgari PV, Markatseli TE, Zioga A, Drosos AA (2009) Immune-mediated skin lesions in patients treated with anti-tumour necrosis factor alpha inhibitors. Scand J Rheumatol 38:328\u2013331. \n                    https:\/\/doi.org\/10.1080\/03009740902922612","journal-title":"Scand J Rheumatol"},{"key":"4212_CR4","doi-asserted-by":"publisher","first-page":"2513","DOI":"10.1002\/art.21233","volume":"52","author":"PP Sfikakis","year":"2005","unstructured":"Sfikakis PP, Iliopoulos A, Elezoglou A, Kittas C, Stratigos A (2005) Psoriasis induced by anti-tumor necrosis factor therapy: a paradoxical adverse reaction. Arthritis Rheum 52:2513\u20132518","journal-title":"Arthritis Rheum"},{"key":"4212_CR5","first-page":"996","volume":"27","author":"TE Markatseli","year":"2009","unstructured":"Markatseli TE, Kaltsonoudis ES, Voulgari PV, Zioga A, Drosos AA (2009) Induction of psoriatic skin lesions in a patient with rheumatoid arthritis treated with rituximab. Clin Exp Rheumatol 27:996\u2013998","journal-title":"Clin Exp Rheumatol"},{"key":"4212_CR6","doi-asserted-by":"publisher","first-page":"R125","DOI":"10.1186\/ar4582","volume":"16","author":"E Kaltsonoudis","year":"2014","unstructured":"Kaltsonoudis E, Zikou AK, Voulgari PV, Konitsiotis S, Argyropoulou MI, Drosos AA (2014) Neurological adverse events in patients receiving anti-TNF therapy: a prospective imaging and electrophysiological study. Arthritis Res Ther 16:R125. \n                    https:\/\/doi.org\/10.1186\/ar4582","journal-title":"Arthritis Res Ther"},{"key":"4212_CR7","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1136\/ard.2007.075663","volume":"67","author":"PV Voulgari","year":"2008","unstructured":"Voulgari PV, Markatseli TE, Exarchou SA, Zioga A, Drosos AA (2008) Granuloma annulare induced by anti-tumour necrosis factor therapy. Ann Rheum Dis 67:567\u2013570","journal-title":"Ann Rheum Dis"},{"key":"4212_CR8","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1007\/s00296-011-1999-3","volume":"31","author":"AY Gasparyan","year":"2011","unstructured":"Gasparyan AY, Ayvazyan L, Blackmore H, Kitas GD (2011) Writing a narrative biomedical review: considerations for authors, peer reviewers, and editors. Rheumatol Int 31:1409\u20131417. \n                    https:\/\/doi.org\/10.1007\/s00296-011-1999-3","journal-title":"Rheumatol Int"},{"key":"4212_CR9","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.amjmed.2005.12.002","volume":"119","author":"JS Alexander","year":"2006","unstructured":"Alexander JS, Paniker PU (2006) A ring-shaped eruption. Am J Med 119:125\u2013127","journal-title":"Am J Med"},{"key":"4212_CR10","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.det.2015.03.001","volume":"33","author":"EL Keimig","year":"2015","unstructured":"Keimig EL. Granuloma, Annulare (2015) Granuloma annulare. Dermatol Clin 33:315\u201329. \n                    https:\/\/doi.org\/10.1016\/j.det.2015.03.001","journal-title":"Dermatol Clin"},{"key":"4212_CR11","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1159\/000069965","volume":"206","author":"SA Devos","year":"2003","unstructured":"Devos SA, Van Den Bossche N, De Vos M, Naeyaert JM (2003) Adverse skin reactions to anti-TNF-alpha monoclonal antibody therapy. Dermatology 206:388\u2013390","journal-title":"Dermatology"},{"key":"4212_CR12","doi-asserted-by":"publisher","first-page":"752","DOI":"10.4103\/0019-5154.91847","volume":"56","author":"M Ratnarathorn","year":"2011","unstructured":"Ratnarathorn M, Raychaudhuri SP, Naguwa S (2011) Disseminated granuloma annulare: a cutaneous adverse effect of anti-TNF agents. Indian J Dermatol 56:752\u2013754. \n                    https:\/\/doi.org\/10.4103\/0019-5154.91847","journal-title":"Indian J Dermatol"},{"key":"4212_CR13","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.annder.2009.10.003","volume":"137","author":"M Viguier","year":"2010","unstructured":"Viguier M, Richette P, Bachelez H, Wendling D, Aubin F (2010) Paradoxical cutaneous manifestations during anti-TNF-alpha therapy. Ann Dermatol Venereol 137:64\u201371. \n                    https:\/\/doi.org\/10.1016\/j.annder.2009.10.003\n                    \n                  . quiz 63, 78 \u2013 9.","journal-title":"Ann Dermatol Venereol"},{"key":"4212_CR14","doi-asserted-by":"publisher","first-page":"5918708","DOI":"10.1155\/2017\/5918708","volume":"2017","author":"L Bonomo","year":"2017","unstructured":"Bonomo L, Ghoneim S, Levitt J (2017) A case of granuloma annulare associated with secukinumab use. Case Rep Dermatol Med 2017:5918708. \n                    https:\/\/doi.org\/10.1155\/2017\/5918708","journal-title":"Case Rep Dermatol Med"},{"key":"4212_CR15","doi-asserted-by":"publisher","unstructured":"Clark ML, Tobin CA, Sutton A, Missall TA. Granuloma annulare in the setting of secukinumab. Case Rep Dermatol Med 2018:5175319. \n                    https:\/\/doi.org\/10.1155\/2018\/5175319","DOI":"10.1155\/2018\/5175319"},{"issue":"3","key":"4212_CR16","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.jaad.2015.03.054","volume":"75","author":"EW Piette","year":"2016","unstructured":"Piette EW, Rosenbach M (2016) Granuloma annulare: clinical and histologic variants, epidemiology, and genetics. J Am Acad Dermatol 75(3):457\u2013465. \n                    https:\/\/doi.org\/10.1016\/j.jaad.2015.03.054","journal-title":"J Am Acad Dermatol"},{"key":"4212_CR17","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1111\/dth.12222","volume":"28","author":"FL Sand","year":"2015","unstructured":"Sand FL, Thomsen SF (2015) Off-label use of TNF-alpha inhibitors in a dermatological university department: retrospective evaluation of 118 patients. Dermatol Ther 28:158\u2013165. \n                    https:\/\/doi.org\/10.1111\/dth.12222","journal-title":"Dermatol Ther"},{"key":"4212_CR18","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1016\/S0140-6736(16)00560-2","volume":"387","author":"PM Villiger","year":"2016","unstructured":"Villiger PM, Adler S, Kuchen S, Wermelinger F, Dan D, Fiege V, B\u00fctikofer L, Seitz M, Reichenbach S (2016) Tocilizumab for induction and maintenance of remission in giant cell arteritis: a phase 2, randomised, double-blind, placebo-controlled trial. Lancet 387:1921\u20131927. \n                    https:\/\/doi.org\/10.1016\/S0140-6736(16)00560-2","journal-title":"Lancet"},{"issue":"11","key":"4212_CR19","doi-asserted-by":"publisher","first-page":"3788","DOI":"10.1002\/art.34647","volume":"64","author":"M Samson","year":"2012","unstructured":"Samson M, Audia S, Fraszczak J et al (2012) Th1 and Th17 lymphocytes expressing CD161 are implicated in giant cell arteritis and polymyalgia rheumatica pathogenesis. Arthritis Rheum 64(11):3788\u20133798","journal-title":"Arthritis Rheum"},{"issue":"2","key":"4212_CR20","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.cyto.2008.09.004","volume":"44","author":"VM Martinez-Taboada","year":"2008","unstructured":"Martinez-Taboada VM, Alvarez L, RuizSoto M et al (2008) Giant cell arteritis and polymyalgia rheumatica: role of cytokines in the pathogenesis and implications for treatment. Cytokine 44(2):207\u2013220","journal-title":"Cytokine"},{"key":"4212_CR21","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1097\/00002281-200307000-00003","volume":"15","author":"PP Sfikakis","year":"2003","unstructured":"Sfikakis PP, Kollias G (2003) Tumor necrosis factor biology in experimental and clinical arthritis. Curr Opin Rheumatol 15:380\u2013386","journal-title":"Curr Opin Rheumatol"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00296-018-4212-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-018-4212-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-018-4212-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,12,6]],"date-time":"2019-12-06T19:09:01Z","timestamp":1575659341000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00296-018-4212-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,7]]},"references-count":21,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["4212"],"URL":"https:\/\/doi.org\/10.1007\/s00296-018-4212-0","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12,7]]},"assertion":[{"value":"8 October 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 December 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"E. Pelechas, Alexandra Papoudou-Bai, Paraskevi V. Voulgari, and Alexandros A. Drosos declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from our patient included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}